{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:28Z","timestamp":1707524488593},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,11]]},"DOI":"10.7759\/cureus.23076","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T19:54:11Z","timestamp":1647028451000},"source":"Crossref","is-referenced-by-count":0,"title":["Dapsone as a Detrimental Cause of Necrotizing Fasciitis With Severe Resistant Neutropenia: A Case Report"],"prefix":"10.7759","author":[{"given":"Juwairiah","family":"Abdur Raheem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshiya","family":"Unnisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Iqubal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2314379","article-title":"A case of dapsone-induced severe agranulocytosis causing life-threatening skin sepsis in a Sri Lankan child with borderline leprosy: a success story!","volume":"2019","author":"Fernando M","year":"2019","unstructured":"Fernando M, Kankananarachchi I, Navabalasooriyar P, Herath B, Punchihewa P. A case of dapsone-induced severe agranulocytosis causing life-threatening skin sepsis in a Sri Lankan child with borderline leprosy: a success story!. Case Rep Med. 2019, 2019:2314379. 10.1155\/2019\/2314379","journal-title":"Case Rep Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-013-1409-7","article-title":"Dapsone in dermatology and beyond","volume":"306","author":"Wozel G","year":"2014","unstructured":"Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res. 2014, 306:103-124. 10.1007\/s00403-013-1409-7","journal-title":"Arch Dermatol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903002097","article-title":"An evaluation of dapsone gel 5% in the treatment of acne vulgaris","volume":"10","author":"Pickert A","year":"2009","unstructured":"Pickert A, Raimer S. An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009, 10:1515-1521. 10.1517\/14656560903002097","journal-title":"Expert Opin Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1574886313666180731123232","article-title":"Dapsone hypersensitivity syndrome (DHS): a detrimental effect of dapsone? A case report","volume":"14","author":"Shukkoor AA","year":"2019","unstructured":"Shukkoor AA, Thangavelu S, George NE, Priya S. Dapsone hypersensitivity syndrome (DHS): a detrimental effect of dapsone? A case report. Curr Drug Saf. 2019, 14:37-39. 10.2174\/1574886313666180731123232","journal-title":"Curr Drug Saf"},{"key":"ref5","article-title":"Dapsone","author":"Sago J","year":"2012","unstructured":"Sago J, Hall RP III. Dapsone. Fitzpatrick's Dermatology in General Medicine. McGraw Hill, 2012. 340-351."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(94)31098-0","article-title":"Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid","volume":"101","author":"Raizman MB","year":"1994","unstructured":"Raizman MB, Fay AM, Weiss JS. Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid. Ophthalmology. 1994, 101:1805-1807. 10.1016\/s0161-6420(94)31098-0","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1258\/0022215042450698","article-title":"Cervicofacial necrotizing fasciitis: can we expect a favourable outcome?","volume":"118","author":"Panda NK","year":"2004","unstructured":"Panda NK, Simhadri S, Sridhara SR. Cervicofacial necrotizing fasciitis: can we expect a favourable outcome?. J Laryngol Otol. 2004, 118:771-777. 10.1258\/0022215042450698","journal-title":"J Laryngol Otol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670310081011","article-title":"The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988","volume":"126","author":"H\u00f6rnsten P","year":"1990","unstructured":"H\u00f6rnsten P, Keisu M, Wiholm BE. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol. 1990, 126:919-922. 10.1001\/archderm.1990.01670310081011","journal-title":"Arch Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/s1413-86702009000200018","article-title":"Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report","volume":"13","author":"da Silva IM","year":"2009","unstructured":"da Silva IM, de Oliveira CA, de Guedes WR, de Oliveira BB, de Oliveira DA, Guedes Filho G. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report. Braz J Infect Dis. 2009, 13:158-160. 10.1590\/s1413-86702009000200018","journal-title":"Braz J Infect Dis"},{"key":"ref10","article-title":"Management and preventive measures for febrile neutropenia","volume":"43","author":"Lucas AJ","year":"2018","unstructured":"Lucas AJ, Olin JL, Coleman MD. Management and preventive measures for febrile neutropenia. P T. 2018, 43:228-232.","journal-title":"P T"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-2-185","article-title":"Neutropenic sepsis: management and complications","volume":"13","author":"Littlewood TJ","year":"2013","unstructured":"Littlewood TJ, Clarke RT, Jenyon T, van Hamel Parsons V, King AJ. Neutropenic sepsis: management and complications. Clin Med (Lond). 2013, 13:185-187. 10.7861\/clinmedicine.13-2-185","journal-title":"Clin Med (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-1-125","article-title":"Late diagnosed necrotizing fasciitis as a cause of multiorgan dysfunction syndrome: a case report","volume":"1","author":"Smuszkiewicz P","year":"2008","unstructured":"Smuszkiewicz P, Trojanowska I, Tomczak H. Late diagnosed necrotizing fasciitis as a cause of multiorgan dysfunction syndrome: a case report. Cases J. 2008, 1:125. 10.1186\/1757-1626-1-125","journal-title":"Cases J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.03.023","article-title":"Sepsis-associated in-hospital cardiac arrest: epidemiology, pathophysiology, and potential therapies","volume":"40","author":"Morgan RW","year":"2017","unstructured":"Morgan RW, Fitzgerald JC, Weiss SL, Nadkarni VM, Sutton RM, Berg RA. Sepsis-associated in-hospital cardiac arrest: epidemiology, pathophysiology, and potential therapies. J Crit Care. 2017, 40:128-135. 10.1016\/j.jcrc.2017.03.023","journal-title":"J Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87048-dapsone-as-a-detrimental-cause-of-necrotizing-fasciitis-with-severe-resistant-neutropenia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:38Z","timestamp":1707507698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87048-dapsone-as-a-detrimental-cause-of-necrotizing-fasciitis-with-severe-resistant-neutropenia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.23076","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,11]]}}}